- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Vertex Pharmaceuticals Inc
+ Add to WatchlistVRTX:US
79.4900 USD 1.6000 2.05%As of 20:10:00 ET on 05/17/2013.
Company Profile for Vertex Pharmaceuticals Inc (VRTX)
Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes novel, small molecule pharmaceuticals for the treatment of diseases for which there are currently limited or no effective treatments. The Company is developing drugs for the treatment of viral diseases, multidrug resistance in cancer, inflammatory and autoimmune diseases, and neurodegenerative diseases.
Contact Information
Vertex Pharmaceuticals Inc
130 Waverly Street
Cambridge, MA 02139-4242
United States
Key Executives for Vertex Pharmaceuticals Inc (VRTX)
| Jeffrey M LeidenChairman/President/CEO | Ian F SmithExec VP/CFO |
| Stuart A ArbuckleExec VP/Chief Commercial Ofcr | Kenneth L Horton "Ken"Exec VP/Chief Legal Officer |
| Peter MuellerExec VP:Global Research & Dev | Amit K SachdevSenior VP:Global Government Strategy |
| Christiana StamoulisSenior VP:Corporate Strategy | Paul M SilvaSenior VP/Corporate Controller |
| Kelly LewisDirector:Investor Relations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page